271 related articles for article (PubMed ID: 6368413)
1. Reversal reaction in lepromatous patients induced by a vaccine containing killed ICRC bacilli--a report of five cases.
Bhatki WS; Chulawala RG; Bapat CV; Deo MG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):466-72. PubMed ID: 6368413
[TBL] [Abstract][Full Text] [Related]
2. Potential anti-leprosy vaccine from killed ICRC bacilli--a clinicopathological study.
Deo MG; Bapat CV; Chullawalla RG; Bhatki WS
Indian J Med Res; 1981 Aug; 74():164-77. PubMed ID: 7030942
[No Abstract] [Full Text] [Related]
3. Effects of ICRC antileprosy vaccine in healthy subjects.
Chaturvedi RM; Chirmule NB; Yellapurkar MV; Shaikh SU; Deo MG
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4):657-66. PubMed ID: 3323368
[TBL] [Abstract][Full Text] [Related]
4. Antileprosy potentials of ICRC vaccine. A study in patients and healthy volunteers.
Deo MG; Bapat CV; Bhalerao V; Chaturvedi RM; Bhatki WS; Chulawala RG
Int J Lepr Other Mycobact Dis; 1983 Dec; 51(4):540-9. PubMed ID: 6368417
[No Abstract] [Full Text] [Related]
5. Comparative study of skin reactions in leprosy patients to M. leprae-lepromin and to ICRC-in, an antigen from cultivable acid-fast bacilli from M. leprae isolated from lepromatous nodules.
Bapat CV; Modak MS; DeSouza NG; Chulawalla RG
Lepr India; 1977 Oct; 49(4):472-84. PubMed ID: 342823
[TBL] [Abstract][Full Text] [Related]
6. Pilot study to determine acceptability and ability of heat-killed Mycobacterium leprae plus BCG (HKML+BCG) vaccine to induce skin test conversion.
Chen ZL; Tang QG; Wang ZM; Chen J
Lepr Rev; 1993 Jun; 64(2):117-27. PubMed ID: 8341114
[TBL] [Abstract][Full Text] [Related]
7. Sensitization potential and reactogenicity of BCG with and without various doses of killed Mycobacterium leprae.
Gupte MD; Anantharaman DS; De Britto RL; Vallishayee RS; Nagaraju B; Kannan S; Sengupta U
Int J Lepr Other Mycobact Dis; 1992 Sep; 60(3):340-52. PubMed ID: 1474275
[TBL] [Abstract][Full Text] [Related]
8. Immunological properties of M. leprae culture isolates ICRC bacilli: hypothesis on relationship between M. leprae and ML-culture isolates.
Bapat CV
Acta Leprol; 1984; 2(2-4):175-94. PubMed ID: 6442820
[TBL] [Abstract][Full Text] [Related]
9. Response of Mycobacterium habana vaccine in patients with lepromatous leprosy and their household contacts. A pilot clinical study.
Wakhlu A; Gaur SP; Kaushal GP; Misra A; Asthana P; Sircar AR
Lepr Rev; 2001 Jun; 72(2):179-91. PubMed ID: 11495449
[TBL] [Abstract][Full Text] [Related]
10. Immunogenic "subunit" of the ICRC antileprosy vaccine.
Chirmule NB; Chaturvedi RM; Deo MG
Int J Lepr Other Mycobact Dis; 1988 Mar; 56(1):27-35. PubMed ID: 3131465
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy of far-advanced lepromatous leprosy patients with low-dose convit vaccine along with multidrug therapy (Calcutta trial).
Majumder V; Mukerjee A; Hajra SK; Saha B; Saha K
Int J Lepr Other Mycobact Dis; 1996 Mar; 64(1):26-36. PubMed ID: 8627110
[TBL] [Abstract][Full Text] [Related]
12. Induction of lepromin positivity by a candidate anti-leprosy vaccine Mycobacterium w in lepromin negative healthy contacts of multibacillary leprosy patients.
Kar HK; Sharma AK; Misra RS; Zaheer SA; Mukherjee A; Mukherjee R; Beena KR; Kaur H; Nair SK; Talwar GP
Indian J Lepr; 1992; 64(4):495-500. PubMed ID: 1308525
[TBL] [Abstract][Full Text] [Related]
13. An eight-year field trial on antileprosy vaccines among high-risk household contacts in the Calcutta metropolis.
Chaudhury S; Hazra SK; Saha B; Mazumder B; Biswas PC; Chattopadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1994 Sep; 62(3):389-94. PubMed ID: 7963911
[TBL] [Abstract][Full Text] [Related]
14. Lepromin conversion induced by a 'sub-unit' vaccine from ICRC bacilli.
Bhatki WS; Chullawala RG; Chaturvedi RM; Dixit GM; Deo MG
Indian J Med Res; 1988 Jun; 87():545-54. PubMed ID: 3071521
[No Abstract] [Full Text] [Related]
15. ICRC 'anti-leprosy vaccine'.
Deo MG
Vaccine; 1989 Apr; 7(2):92-3. PubMed ID: 2665352
[TBL] [Abstract][Full Text] [Related]
16. Human vaccination studies in normal and contacts of leprosy patients.
Samuel NM; Stanford JL; Rees RJ; Fairbairn T; Adiga RB
Indian J Lepr; 1984; 56(1):36-47. PubMed ID: 6384380
[No Abstract] [Full Text] [Related]
17. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
18. Sensitization and reactogenicity of two doses of candidate antileprosy vaccine Mycobacterium w.
Gupte MD; Vallishayee RS; Anantharaman DS; Britto RL; Nagaraju B
Indian J Lepr; 1996; 68(4):315-24. PubMed ID: 9001899
[TBL] [Abstract][Full Text] [Related]
19. ICRC vaccine-induced changes in M. leprae-specific cell-mediated immunity in langur (Presbytis entellus) monkeys.
Chirmule NB; Deo MG; Sirodkar MV; Deshmukh R; Chanderkar NG
Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):57-62. PubMed ID: 3519805
[TBL] [Abstract][Full Text] [Related]
20. Simultaneous upgrading reaction and erythema nodosum leprosum in a patient with lepromatous leprosy.
Job CK; Jacobson RR; Hastings RC
Int J Lepr Other Mycobact Dis; 1988 Sep; 56(3):437-42. PubMed ID: 3418207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
